Abhinav Sidana to Magnetic Resonance Imaging
This is a "connection" page, showing publications Abhinav Sidana has written about Magnetic Resonance Imaging.
Connection Strength
2.188
-
How does a prebiopsy mri approach for prostate cancer diagnosis affect prostatectomy upgrade rates? Urol Oncol. 2021 11; 39(11):784.e11-784.e16.
Score: 0.312
-
Multiparametric MRI: An Opportunity for Focal Therapy of Prostate Cancer. Semin Roentgenol. 2018 Jul; 53(3):227-233.
Score: 0.256
-
Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis. Urol Oncol. 2018 Jul; 36(7):341.e1-341.e7.
Score: 0.255
-
Imaging Prostate Cancer Using Multiparametric Magnetic Resonance Imaging: Past, Present, and Future. Semin Roentgenol. 2018 Jul; 53(3):200-205.
Score: 0.254
-
Magnetic resonance imaging-ultrasound fusion guided focal cryoablation for men with intermediate-risk prostate cancer. Urol Oncol. 2024 05; 42(5):158.e1-158.e10.
Score: 0.094
-
Real-Time and Delayed Imaging of Tissue and Effects of Prostate Tissue Ablation. Curr Urol Rep. 2023 Oct; 24(10):477-489.
Score: 0.091
-
Does the type of biopsy used for diagnosis impact subsequent treatment selection in prostate cancer patients? Aging Male. 2022 Dec; 25(1):23-28.
Score: 0.087
-
Multiparametric MRI-ultrasound fusion prostate biopsy in patients without prior diagnosis of prostate cancer: beyond centers of excellence. Aging Male. 2020 Dec; 23(5):1570-1575.
Score: 0.077
-
A Comparison of Cancer Detection Rates Between Template Systematic Biopsies Obtained Using Magnetic Resonance Imaging-Ultrasound Fusion Machine and Freehand Transrectal Ultrasound-Guided Systematic Biopsies. J Endourol. 2020 10; 34(10):1095-1098.
Score: 0.075
-
Index tumor volume on MRI as a predictor of clinical and pathologic outcomes following radical prostatectomy. Int Urol Nephrol. 2019 Aug; 51(8):1349-1355.
Score: 0.068
-
Partial gland therapy for prostate cancer. Cancer. 2019 03 01; 125(5):818-819.
Score: 0.066
-
False-Positive Prostate Imaging Reporting and Data System Version 2 Category 5 Lesions: A Discussion of Possible Mechanisms. AJR Am J Roentgenol. 2018 11; 211(5):W277.
Score: 0.066
-
Prostate Cancer and Prostate Imaging Reporting and Data System Category 3 Lesions Identified at Multiparametric Prostate MRI. AJR Am J Roentgenol. 2018 06; 210(6):W268.
Score: 0.064
-
Ruling out clinically significant prostate cancer with negative multi-parametric MRI. Int Urol Nephrol. 2018 Jan; 50(1):7-12.
Score: 0.062
-
MRI-targeted biopsy: is systematic biopsy obsolete? Can J Urol. 2017 Aug; 24(4):8876-8882.
Score: 0.060
-
Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance-targeted biopsy. Urol Oncol. 2017 01; 35(1):32.e1-32.e7.
Score: 0.057
-
Missing the Mark: Prostate Cancer Upgrading by Systematic Biopsy over Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsy. J Urol. 2017 02; 197(2):327-334.
Score: 0.057
-
Tumor contact with prostate capsule on magnetic resonance imaging: A potential biomarker for staging and prognosis. Urol Oncol. 2017 01; 35(1):30.e1-30.e8.
Score: 0.057
-
Midline lesions of the prostate: role of MRI/TRUS fusion biopsy and implications in Gleason risk stratification. Int Urol Nephrol. 2016 Sep; 48(9):1445-52.
Score: 0.056
-
The significance of anterior prostate lesions on multiparametric magnetic resonance imaging in African-American men. Urol Oncol. 2016 06; 34(6):254.e15-21.
Score: 0.055
-
MRI-guided focal laser ablation of prostate cancer: a prospective single-arm, single-center trial with 3 years of follow-up. Diagn Interv Radiol. 2021 May; 27(3):394-400.
Score: 0.020